About Reacta Biotech
Reacta Biotech is a company based in Manchester (United Kingdom) founded in 2013 by Clare Mills.. Reacta Biotech has raised $5.58 million across 3 funding rounds from investors including Development Bank of Wales, Praetura Ventures and Acceleris Capital. The company has 16 employees as of December 31, 2021. Reacta Biotech offers products and services including Challenge Meals and Oral Food Challenges. Reacta Biotech operates in a competitive market with competitors including Nestlé Health Science, Mahmi Foods and Glutagen, among others.
- Headquarter Manchester, United Kingdom
- Employees 16 as on 31 Dec, 2021
- Founders Clare Mills
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Reacta Biotech Limited
- Date of Incorporation 03 Jun, 2013
- Jurisdiction DEESIDE, ENGLAND
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$5.58 M (USD)
in 3 rounds
-
Latest Funding Round
$4.02 M (USD), Series B
Jul 14, 2021
-
Investors
Development Bank of Wales
& 2 more
-
Employee Count
16
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Reacta Biotech
Reacta Biotech offers a comprehensive portfolio of products and services, including Challenge Meals and Oral Food Challenges. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Specialized meals for oral food challenges to test and diagnose allergies accurately.
Structured tests using meals to identify food allergies in clinical settings.
Funding Insights of Reacta Biotech
Reacta Biotech has successfully raised a total of $5.58M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $4.02 million completed in July 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $4.0M
- First Round First Round
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Series B - Reacta Biotech | Valuation | Praetura Ventures | |
| Apr, 2020 | Amount | Series A - Reacta Biotech | Valuation | Development Bank of Wales | |
| Jun, 2014 | Amount | Seed - Reacta Biotech | Valuation | Acceleris Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Reacta Biotech
Reacta Biotech has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Development Bank of Wales, Praetura Ventures and Acceleris Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital funding is provided by Praetura Ventures.
|
Founded Year | Domain | Location | |
|
Provider of equity funding and business & property development loans
|
Founded Year | Domain | Location | |
|
Provides expert VC fundraising and advisory services for ambitious tech founders.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Reacta Biotech
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Reacta Biotech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Reacta Biotech Comparisons
Competitors of Reacta Biotech
Reacta Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nestlé Health Science, Mahmi Foods and Glutagen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Nutritional dietary supplements are provided for health and wellness needs.
|
|
| domain | founded_year | HQ Location |
Hypoallergenic novel food products are developed using fermentation-based technology.
|
|
| domain | founded_year | HQ Location |
Develops and commercializes therapeutics for gluten-related health issues using enzyme therapy.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Reacta Biotech
Frequently Asked Questions about Reacta Biotech
When was Reacta Biotech founded?
Reacta Biotech was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Where is Reacta Biotech located?
Reacta Biotech is headquartered in Manchester, United Kingdom. It is registered at Manchester, Greater Manchester, United Kingdom.
Is Reacta Biotech a funded company?
Reacta Biotech is a funded company, having raised a total of $5.58M across 3 funding rounds to date.
How many employees does Reacta Biotech have?
As of Dec 31, 2021, the latest employee count at Reacta Biotech is 16.
What does Reacta Biotech do?
Reacta Biotech was founded in 2013 in Manchester, United Kingdom, within the biotechnology sector. Oral food challenge materials are developed and manufactured to standardize clinical food allergy testing. A proprietary stable food matrix is prepared through a controlled process adhering to food and pharmaceutical manufacturing standards. Collaboration with the Manchester Institute of Biotechnology has enabled profiling of allergen molecules in food ingredients, with peanut allergen stability confirmed via mass spectrometry.
Who are the top competitors of Reacta Biotech?
Reacta Biotech's top competitors include Nestlé Health Science, Mahmi Foods and Glutagen.
What products or services does Reacta Biotech offer?
Reacta Biotech offers Challenge Meals and Oral Food Challenges.
Who are Reacta Biotech's investors?
Reacta Biotech has 3 investors. Key investors include Development Bank of Wales, Praetura Ventures, and Acceleris Capital.